Descontinuación del esteroide inhalado en pacientes con enfermedad pulmonar obstructiva crónica moderada a severa no aumenta el riesgo de exacerbaciones

Carlos Andrés Celis Preciado, MD.

Texto completo:



From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. Disponible en: Fecha de acceso: 10/09/14.

Babu KS, Kastelik JA, Morjaria JB. Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. Br J Clin Pharmacol. 2014;78(2):282-300.

Halpin DM, Quint JK. The WISDOM of inhaled corticosteroids in COPD. Thorax. 2014;69(12):1071-2.

Agustí A. Inhaled steroids in COPD: Reasons for a debate. Rev Port Pneumol (2006). 2015;21(4):175-7.

Laniado-Laborín R. Discontinuing inhaled steroids might not be safe in severe COPD cases. Evid Based Med. 2015;20(2):57.

Stanbrook MB. ACP journal club. For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation. Ann Intern Med. 2015;162(6):JC5.

Balkissoon R. Journal club. J COPD F. 2015; 2(1): 85-90.

Rodriguez Roisin R, Arismendi E. Inhaled corticosteroids withdrawal in severe patients with chronic obstructive pulmonary disease: a wisdom decision? Arch Bronconeumol. 2015;51(2):57-8.

Cazzola M, Rogliani P, Matera MG. Escalation and de-escalation of therapy in COPD: myths, realities and perspectives. Drugs. 2015. [Epub ahead of print].

Rossi A, van der Molen T, del Olmo R, Papi A, Wehbe L, Quinn M, et al. INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. Eur Respir J. 2014;44(6):1548-56.

Rossi A, Guerriero M, Corrado A. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD

patients (OPTIMO). Respir Res. 2014;15:77.

Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group. Thorax. 2005;60(6):480-7.

Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3:CD010115.

Festic E, Scanlon PD. Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids? Am J Respir Crit Care Med. 2015;191(2):141-8.

Ni S, Fu Z, Zhao J, Liu H. Inhaled corticosteroids (ICS) and risk of mycobacterium in patients with chronic respiratory diseases: a metaanalysis. J Thorac Dis. 2014;6(7):971-8.

Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68(3):256-62.

Dong YH, Chang CH, Lin Wu FL, Shen LJ, Calverley PM, Löfdahl CG, et al. Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. Chest. 2014;145(6):1286-97.

Gläser S, Krüger S, Merkel M, Bramlage P, Herth FJ. Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature. Respiration. 2015;89(3):253-64.

Weatherall M, Clay J, James K, Perrin K, Shirtcliffe P, Beasley R. Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis. Respirology. 2009;14(7):983-90.

Battaglia S, Cardillo I, Lavorini F, Spatafora M, Scichilone N. Safety considerations of inhaled corticosteroids in the elderly. Drugs Aging. 2014;31(11):787-96.

Agusti A, Fabbri LM. Inhaled steroids in COPD: when should they be used? Lancet Respir Med. 2014;2(11):869-71.


Métricas de artículo

Vistas de resumen

Cargando métricas ...

Enlaces refback

  • No hay ningún enlace refback.

Asociación Colombiana de Neumología y Cirugía de Tórax.
Dirección: Carrera 7 Bis # 123-52 Of. 202, Teléfono: 57(1)3222335 - Bogotá - Colombia.
Sistema OJS - Metabiblioteca |